The SARS-CoV-2 spike protein receptor-binding domain expressed in rice callus features a homogeneous mix of complex-type glycans

The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is required for the infection of human cells. It is the main target that elicits neutralizing antibodies and also a major component of diagnostic kits. The large demand for this protein has led to the use of plants as a production platfor...

Descripción completa

Detalles Bibliográficos
Autores: Sobrino-Mengual, Guillermo, Armario-Najera, Victoria, Balieu, Juliette, Walet-Balieu, Marie-Laure, Saba-Mayoral, Andrea, Pelacho Aja, Ana Mª, Capell Capell, Teresa, Christou, Paul, Bardor, Muriel, Lerouge, Patrice
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10459.1/465825
Acceso en línea:https://doi.org/10.3390/ijms25084466
https://hdl.handle.net/10459.1/465825
Access Level:acceso abierto
Palabra clave:Plant molecular farming
Receptor-binding domain
Glycan profile
Biologics
Descripción
Sumario:The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is required for the infection of human cells. It is the main target that elicits neutralizing antibodies and also a major component of diagnostic kits. The large demand for this protein has led to the use of plants as a production platform. However, it is necessary to determine the N-glycan structures of an RBD to investigate its efficacy and functionality as a vaccine candidate or diagnostic reagent. Here, we analyzed the N-glycan profile of the RBD produced in rice callus. Of the two potential N-glycan acceptor sites, we found that one was not utilized and the other contained a mixture of complex-type N-glycans. This differs from the heterogeneous mixture of N-glycans found when an RBD is expressed in other hosts, including Nicotiana benthamiana. By comparing the glycosylation profiles of different hosts, we can select platforms that produce RBDs with the most beneficial N-glycan structures for different applications.